Wen Liu

34PUBLICATIONS
77CO-AUTHORS
Molecular targetsMicrobial geneticsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jun 22, 2026
Large-scale and high-resolution mass spectrometry-based proteomics defines molecular subtypes of nasopharyngeal carcinoma for therapeutic targeting.

|May 20, 2026
Arginine Di-methylation of RIP3 safeguards necroptosis for intestinal homeostasis.

|May 19, 2026
Spatial single-cell landscape of tumor-associated macrophages and their crosstalk with the tumor microenvironment.

|Apr 10, 2026
Casein kinase 2-mediated phosphorylation of the splicing factor SF3B3 plays a key role in esophageal squamous cell carcinoma progression.

Du-Chuang Wang, Jia-Yuan Li, Xiao-Bing Wang

|Apr 07, 2026
Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study.

Shuang Huang, Feng Liu, Song Qu

|Feb 18, 2026
ERRα-KDM5C restrains STING enhancer activity to modulate type I interferon signaling in breast cancer progression.

Zu-Hui Xu, Jie Chen, Ying He

Pageof 6

Frequent Collaborators

8 joint publications

Yaohui He

2 joint publications

Jia Yi

2 joint publications

Bin Zheng

2 joint publications

Ting Ran